IDEVAX is excited to announce that our paper titled “Preclinical evaluation of performance, safety and usability of VAX-ID®, a novel intradermal injection device” by Beyers & Rbeihat et al. is published in the prestigious Vaccine journal by Elsevier
IDEVAX is continuously committed to advancing scientific research and innovation. Our latest publication in the Vaccine journal further reinforces our dedication to making significant contributions to the field of vaccine development and delivery.
Interested in our solutions?
Contact our commercial team!